Drug Discovery Outsourcing Market By Drug Type (Small Molecule and Large Molecule), By Service Type (Target Identification & Screening, Target Discovery & Validation, Hit Identification/High-Throughput Screening, Hit-to-Lead Development, Lead Optimization, Preclinical Testing Services and Others), By Therapeutic Area (Oncology, Neurology/CNS Disorders, Infectious Diseases, Cardiovascular Diseases, Immunology & Inflammatory Disorders, Metabolic & Endocrine Disorders, Respiratory Diseases, Gastrointestinal Disorders, Rare/Orphan Diseases, Ophthalmology Diseases, Dermatology Diseases and Others), By End-User (Pharmaceutical & Biotechnology Companies and Academic & Research Institutes), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
  • 1.8. Industry Voices
• 2. Global Market Overview
  • 2.1. Global Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunities
    • 2.2.4. Key Drug Discovery Outsourcing Market Trends
  • 2.3. Technology Landscape
  • 2.4. Regulatory Framework
  • 2.5. Sustainability and ESG (Environmental, Social, Governance)
  • 2.6. Opportunity Map Analysis
  • 2.7. Opportunity Orbits
  • 2.8. PESTLE Analysis
  • 2.9. PORTER’S Five Force Analysis
  • 2.10. Drivers & Restraints Impact Analysis
  • 2.11. Value Chain Analysis
    • 2.11.1. List of Raw Materials Suppliers
    • 2.11.2. List of Drug Discovery Outsourcing Manufacturers
    • 2.11.3. List of Dealer/Distributors
  • 2.12. Regional Market Share and BPS Analysis
  • 2.13. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Drug Discovery Outsourcing Market Analysis and Forecast, By Segment, 2020-2034
  • 3.1. Key Findings
  • 3.2. Global Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Type, 2020-2034
  • 3.3. Global Drug Discovery Outsourcing Market Attractiveness Analysis, By Drug Type
    • 3.3.1. Small molecule
      • 3.3.1.1. Insights
      • 3.3.1.2. Key Takeaways
    • 3.3.2. Large molecule
      • 3.3.2.1. Insights
      • 3.3.2.2. Key Takeaways
  • 3.4. Global Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Service Type, 2020-2034
  • 3.5. Global Drug Discovery Outsourcing Market Attractiveness Analysis, By Service Type
    • 3.5.1. Target Identification & Screening
      • 3.5.1.1. Insights
      • 3.5.1.2. Key Takeaways
    • 3.5.2. Target Discovery & Validation
      • 3.5.2.1. Insights
      • 3.5.2.2. Key Takeaways
    • 3.5.3. Hit Identification/High-Throughput Screening
      • 3.5.3.1. Insights
      • 3.5.3.2. Key Takeaways
    • 3.5.4. Hit-to-Lead Development
      • 3.5.4.1. Insights
      • 3.5.4.2. Key Takeaways
    • 3.5.5. Lead Optimization
      • 3.5.5.1. Insights
      • 3.5.5.2. Key Takeaways
    • 3.5.6. Preclinical Testing Services
      • 3.5.6.1. Insights
      • 3.5.6.2. Key Takeaways
    • 3.5.7. Others
      • 3.5.7.1. Insights
      • 3.5.7.2. Key Takeaways
  • 3.6. Global Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2020-2034
  • 3.7. Global Drug Discovery Outsourcing Market Attractiveness Analysis, By Therapeutic Area
    • 3.7.1. Oncology
      • 3.7.1.1. Insights
      • 3.7.1.2. Key Takeaways
    • 3.7.2. Neurology/CNS Disorders
      • 3.7.2.1. Insights
      • 3.7.2.2. Key Takeaways
    • 3.7.3. Infectious Diseases
      • 3.7.3.1. Insights
      • 3.7.3.2. Key Takeaways
    • 3.7.4. Cardiovascular Diseases
      • 3.7.4.1. Insights
      • 3.7.4.2. Key Takeaways
    • 3.7.5. Immunology & Inflammatory Disorders
      • 3.7.5.1. Insights
      • 3.7.5.2. Key Takeaways
    • 3.7.6. Metabolic & Endocrine Disorders
      • 3.7.6.1. Insights
      • 3.7.6.2. Key Takeaways
    • 3.7.7. Respiratory Diseases
      • 3.7.7.1. Insights
      • 3.7.7.2. Key Takeaways
    • 3.7.8. Gastrointestinal Disorders
      • 3.7.8.1. Insights
      • 3.7.8.2. Key Takeaways
    • 3.7.9. Rare/Orphan Diseases
      • 3.7.9.1. Insights
      • 3.7.9.2. Key Takeaways
    • 3.7.10. Ophthalmology Diseases
      • 3.7.10.1. Insights
      • 3.7.10.2. Key Takeaways
    • 3.7.11. Dermatology Diseases
      • 3.7.11.1. Insights
      • 3.7.11.2. Key Takeaways
    • 3.7.12. Others
      • 3.7.12.1. Insights
      • 3.7.12.2. Key Takeaways
  • 3.8. Global Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 3.9. Global Drug Discovery Outsourcing Market Attractiveness Analysis, By End-User
    • 3.9.1. Pharmaceutical & Biotechnology Companies
      • 3.9.1.1. Insights
      • 3.9.1.2. Key Takeaways
    • 3.9.2. Academic & Research Institutes
      • 3.9.2.1. Insights
      • 3.9.2.2. Key Takeaways
• 4. Global Drug Discovery Outsourcing Market Analysis and Forecast, By Region, 2020-2034
  • 4.1. Key Findings
  • 4.2. Global Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    • 4.2.1. North America
      • 4.2.1.1. Regional Insights
    • 4.2.2. Europe
      • 4.2.2.1. Regional Insights
    • 4.2.3. Asia Pacific
      • 4.2.3.1. Regional Insights
    • 4.2.4. Latin America
      • 4.2.4.1. Regional Insights
    • 4.2.5. Middle East & Africa
      • 4.2.5.1. Regional Insights
  • 4.3. Global Drug Discovery Outsourcing Market Attractiveness Analysis, By Region
• 5. North America Drug Discovery Outsourcing Market Analysis and Forecast, 2020-2034
  • 5.1. Key Findings
  • 5.2. North America Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Type, 2020-2034
  • 5.3. North America Drug Discovery Outsourcing Market Attractiveness Analysis, By Drug Type
  • 5.4. North America Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Service Type, 2020-2034
  • 5.5. North America Drug Discovery Outsourcing Market Attractiveness Analysis, By Service Type
  • 5.6. North America Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2020-2034
  • 5.7. North America Drug Discovery Outsourcing Market Attractiveness Analysis, By Therapeutic Area
  • 5.8. North America Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 5.9. North America Drug Discovery Outsourcing Market Attractiveness Analysis, By End-User
  • 5.10. North America Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 5.11. North America Drug Discovery Outsourcing Market Attractiveness Analysis, By Country
    • 5.11.1. The US
    • 5.11.2. Canada
• 6. Europe Drug Discovery Outsourcing Market Analysis and Forecast, 2020-2034
  • 6.1. Key Findings
  • 6.2. Europe Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Type, 2020-2034
  • 6.3. Europe Drug Discovery Outsourcing Market Attractiveness Analysis, By Drug Type
  • 6.4. Europe Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Service Type, 2020-2034
  • 6.5. Europe Drug Discovery Outsourcing Market Attractiveness Analysis, By Service Type
  • 6.6. Europe Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2020-2034
  • 6.7. Europe Drug Discovery Outsourcing Market Attractiveness Analysis, By Therapeutic Area
  • 6.8. Europe Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 6.9. Europe Drug Discovery Outsourcing Market Attractiveness Analysis, By End-User
  • 6.10. Europe Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 6.11. Europe Drug Discovery Outsourcing Market Attractiveness Analysis, By Country
    • 6.11.1. Germany
    • 6.11.2. The UK
    • 6.11.3. France
    • 6.11.4. Spain
    • 6.11.5. Italy
    • 6.11.6. Russia
    • 6.11.7. Netherland
    • 6.11.8. Rest of Europe
• 7. Asia Pacific Drug Discovery Outsourcing Market Analysis and Forecast, 2020-2034
  • 7.1. Key Findings
  • 7.2. Asia Pacific Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Type, 2020-2034
  • 7.3. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, By Drug Type
  • 7.4. Asia Pacific Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Service Type, 2020-2034
  • 7.5. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, By Service Type
  • 7.6. Asia Pacific Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2020-2034
  • 7.7. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, By Therapeutic Area
  • 7.8. Asia Pacific Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 7.9. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, By End-User
  • 7.10. Asia Pacific Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 7.11. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, By Country
    • 7.11.1. China
    • 7.11.2. Japan
    • 7.11.3. South Korea
    • 7.11.4. India
    • 7.11.5. Australia
    • 7.11.6. New Zealand
    • 7.11.7. Singapore
    • 7.11.8. Thailand
    • 7.11.9. Vietnam
    • 7.11.10. Rest of Asia Pacific
• 8. Latin America Drug Discovery Outsourcing Market Analysis and Forecast, 2020-2034
  • 8.1. Key Findings
  • 8.2. Latin America Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Type, 2020-2034
  • 8.3. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, By Drug Type
  • 8.4. Latin America Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Service Type, 2020-2034
  • 8.5. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, By Service Type
  • 8.6. Latin America Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2020-2034
  • 8.7. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, By Therapeutic Area
  • 8.8. Latin America Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 8.9. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, By End-User
  • 8.10. Latin America Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 8.11. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, By Country
    • 8.11.1. Brazil
    • 8.11.2. Mexico
    • 8.11.3. Rest of Latin America
• 9. Middle East & Africa Drug Discovery Outsourcing Market Analysis and Forecast, 2020-2034
  • 9.1. Key Findings
  • 9.2. Middle East & Africa Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Type, 2020-2034
  • 9.3. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, By Drug Type
  • 9.4. Middle East & Africa Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Service Type, 2020-2034
  • 9.5. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, By Service Type
  • 9.6. Middle East & Africa Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2020-2034
  • 9.7. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, By Therapeutic Area
  • 9.8. Middle East & Africa Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 9.9. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, By End-User
  • 9.10. Middle East & Africa Drug Discovery Outsourcing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 9.11. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, By Country
    • 9.11.1. South Africa
    • 9.11.2. Saudi Arabia
    • 9.11.3. UAE
    • 9.11.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
  • 10.1. Market Competition Scenario Analysis, By Company
    • 10.1.1. Key Takeaways
  • 10.2. Overview of Major Market Players
  • 10.3. Competitor Landscape
  • 10.4. Strategic Mapping
  • 10.5. Company Life Cycle Analysis
  • 10.6. Company Market Share Analysis
  • 10.7. Company Profiles
    • 10.7.1. IQVIA
      • 10.7.1.1. Company Details
      • 10.7.1.2. Business Overview
      • 10.7.1.3. Product Portfolio
      • 10.7.1.4. Financial Insights
      • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.1.6. SWOT Analysis
      • 10.7.1.7. Geographic Footprint
    • 10.7.2. ICON plc
      • 10.7.2.1. Company Details
      • 10.7.2.2. Business Overview
      • 10.7.2.3. Product Portfolio
      • 10.7.2.4. Financial Insights
      • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.2.6. SWOT Analysis
      • 10.7.2.7. Geographic Footprint
    • 10.7.3. Syneos Health
      • 10.7.3.1. Company Details
      • 10.7.3.2. Business Overview
      • 10.7.3.3. Product Portfolio
      • 10.7.3.4. Financial Insights
      • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.3.6. SWOT Analysis
      • 10.7.3.7. Geographic Footprint
    • 10.7.4. Charles River Laboratories
      • 10.7.4.1. Company Details
      • 10.7.4.2. Business Overview
      • 10.7.4.3. Product Portfolio
      • 10.7.4.4. Financial Insights
      • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.4.6. SWOT Analysis
      • 10.7.4.7. Geographic Footprint
    • 10.7.5. Labcorp
      • 10.7.5.1. Company Details
      • 10.7.5.2. Business Overview
      • 10.7.5.3. Product Portfolio
      • 10.7.5.4. Financial Insights
      • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.5.6. SWOT Analysis
      • 10.7.5.7. Geographic Footprint
    • 10.7.6. WuXi AppTec
      • 10.7.6.1. Company Details
      • 10.7.6.2. Business Overview
      • 10.7.6.3. Product Portfolio
      • 10.7.6.4. Financial Insights
      • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.6.6. SWOT Analysis
      • 10.7.6.7. Geographic Footprint
    • 10.7.7. Parexel
      • 10.7.7.1. Company Details
      • 10.7.7.2. Business Overview
      • 10.7.7.3. Product Portfolio
      • 10.7.7.4. Financial Insights
      • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.7.6. SWOT Analysis
      • 10.7.7.7. Geographic Footprint
    • 10.7.8. Albany Molecular Research Inc.
      • 10.7.8.1. Company Details
      • 10.7.8.2. Business Overview
      • 10.7.8.3. Product Portfolio
      • 10.7.8.4. Financial Insights
      • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.8.6. SWOT Analysis
      • 10.7.8.7. Geographic Footprint
    • 10.7.9. EVOTEC
      • 10.7.9.1. Company Details
      • 10.7.9.2. Business Overview
      • 10.7.9.3. Product Portfolio
      • 10.7.9.4. Financial Insights
      • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.9.6. SWOT Analysis
      • 10.7.9.7. Geographic Footprint
    • 10.7.10. GenScript
      • 10.7.10.1. Company Details
      • 10.7.10.2. Business Overview
      • 10.7.10.3. Product Portfolio
      • 10.7.10.4. Financial Insights
      • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.10.6. SWOT Analysis
      • 10.7.10.7. Geographic Footprint
    • 10.7.11. Thermo Fisher Scientific Inc.
      • 10.7.11.1. Company Details
      • 10.7.11.2. Business Overview
      • 10.7.11.3. Product Portfolio
      • 10.7.11.4. Financial Insights
      • 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.11.6. SWOT Analysis
      • 10.7.11.7. Geographic Footprint
    • 10.7.12. Merck & Co., Inc.
      • 10.7.12.1. Company Details
      • 10.7.12.2. Business Overview
      • 10.7.12.3. Product Portfolio
      • 10.7.12.4. Financial Insights
      • 10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.12.6. SWOT Analysis
      • 10.7.12.7. Geographic Footprint
    • 10.7.13. Dalton Pharma Services
      • 10.7.13.1. Company Details
      • 10.7.13.2. Business Overview
      • 10.7.13.3. Product Portfolio
      • 10.7.13.4. Financial Insights
      • 10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.13.6. SWOT Analysis
      • 10.7.13.7. Geographic Footprint
    • 10.7.14. Oncodesign
      • 10.7.14.1. Company Details
      • 10.7.14.2. Business Overview
      • 10.7.14.3. Product Portfolio
      • 10.7.14.4. Financial Insights
      • 10.7.14.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.14.6. SWOT Analysis
      • 10.7.14.7. Geographic Footprint
    • 10.7.15. Jubilant Biosys
      • 10.7.15.1. Company Details
      • 10.7.15.2. Business Overview
      • 10.7.15.3. Product Portfolio
      • 10.7.15.4. Financial Insights
      • 10.7.15.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.15.6. SWOT Analysis
      • 10.7.15.7. Geographic Footprint
    • 10.7.16. DiscoverX Corp.
      • 10.7.16.1. Company Details
      • 10.7.16.2. Business Overview
      • 10.7.16.3. Product Portfolio
      • 10.7.16.4. Financial Insights
      • 10.7.16.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.16.6. SWOT Analysis
      • 10.7.16.7. Geographic Footprint
    • 10.7.17. QIAGEN
      • 10.7.17.1. Company Details
      • 10.7.17.2. Business Overview
      • 10.7.17.3. Product Portfolio
      • 10.7.17.4. Financial Insights
      • 10.7.17.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.17.6. SWOT Analysis
      • 10.7.17.7. Geographic Footprint
    • 10.7.18. Eurofins SE
      • 10.7.18.1. Company Details
      • 10.7.18.2. Business Overview
      • 10.7.18.3. Product Portfolio
      • 10.7.18.4. Financial Insights
      • 10.7.18.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.18.6. SWOT Analysis
      • 10.7.18.7. Geographic Footprint
    • 10.7.19. Syngene International Limited
      • 10.7.19.1. Company Details
      • 10.7.19.2. Business Overview
      • 10.7.19.3. Product Portfolio
      • 10.7.19.4. Financial Insights
      • 10.7.19.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.19.6. SWOT Analysis
      • 10.7.19.7. Geographic Footprint
    • 10.7.20. Pharmaron Beijing Co., Ltd.
      • 10.7.20.1. Company Details
      • 10.7.20.2. Business Overview
      • 10.7.20.3. Product Portfolio
      • 10.7.20.4. Financial Insights
      • 10.7.20.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.20.6. SWOT Analysis
      • 10.7.20.7. Geographic Footprint
• 11. Methodology and Data Source
  • 11.1. Methodology/Research Approach
  • 11.2. Market Size Estimation
  • 11.3. Market Breakdown and Data Triangulation
  • 11.4. Data Source
  • 11.5. Secondary Sources
  • 11.6. Primary Sources
  • 11.7. Appendix
  • 11.8. Disclaimer

List of Tables

• Table 1. Global Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 2. Global Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 3. Global Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 4. Global Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 5. Global Drug Discovery Outsourcing Market Value (US$ Mn), By Region, 2020-2034
• Table 6. North America Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 7. North America Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 8. North America Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 9. North America Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 10. North America Drug Discovery Outsourcing Market Value (US$ Mn), By Country, 2020-2034
• Table 11. The US Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 12. The US Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 13. The US Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 14. The US Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 15. Canada Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 16. Canada Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 17. Canada Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 18. Canada Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 19. Europe Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 20. Europe Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 21. Europe Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 22. Europe Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 23. Europe Drug Discovery Outsourcing Market Value (US$ Mn), By Country, 2020-2034
• Table 24. Germany Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 25. Germany Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 26. Germany Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 27. Germany Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 28. The UK Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 29. The UK Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 30. The UK Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 31. The UK Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 32. France Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 33. France Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 34. France Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 35. France Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 36. Spain Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 37. Spain Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 38. Spain Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 39. Spain Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 40. Italy Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 41. Italy Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 42. Italy Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 43. Italy Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 44. Russia Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 45. Russia Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 46. Russia Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 47. Russia Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 48. Netherland Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 49. Netherland Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 50. Netherland Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 51. Netherland Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 52. Rest of Europe Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 53. Rest of Europe Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 54. Rest of Europe Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 55. Rest of Europe Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 56. Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 57. Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 58. Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 59. Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 60. Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn), By Country, 2020-2034
• Table 61. China Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 62. China Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 63. China Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 64. China Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 65. India Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 66. India Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 67. India Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 68. India Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 69. Japan Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 70. Japan Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 71. Japan Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 72. Japan Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 73. South Korea Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 74. South Korea Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 75. South Korea Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 76. South Korea Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 77. Australia Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 78. Australia Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 79. Australia Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 80. Australia Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 81. New Zealand Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 82. New Zealand Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 83. New Zealand Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 84. New Zealand Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 85. Singapore Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 86. Singapore Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 87. Singapore Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 88. Singapore Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 89. Thailand Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 90. Thailand Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 91. Thailand Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 92. Thailand Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 93. Vietnam Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 94. Vietnam Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 95. Vietnam Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 96. Vietnam Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 97. Rest of Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 98. Rest of Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 99. Rest of Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 100. Rest of Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 101. Latin America Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 102. Latin America Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 103. Latin America Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 104. Latin America Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 105. Latin America Drug Discovery Outsourcing Market Value (US$ Mn), By Country, 2020-2034
• Table 106. Brazil Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 107. Brazil Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 108. Brazil Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 109. Brazil Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 110. Mexico Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 111. Mexico Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 112. Mexico Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 113. Mexico Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 114. Rest of Latin America Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 115. Rest of Latin America Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 116. Rest of Latin America Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 117. Rest of Latin America Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 118. Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 119. Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 120. Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 121. Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 122. Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn), By Country, 2020-2034
• Table 123. South Africa Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 124. South Africa Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 125. South Africa Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 126. South Africa Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 127. Saudi Arabia Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 128. Saudi Arabia Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 129. Saudi Arabia Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 130. Saudi Arabia Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 131. UAE Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 132. UAE Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 133. UAE Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 134. UAE Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034
• Table 135. Rest of Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn), By Drug Type, 2020-2034
• Table 136. Rest of Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn), By Service Type, 2020-2034
• Table 137. Rest of Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn), By Therapeutic Area, 2020-2034
• Table 138. Rest of Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn), By End-User, 2020-2034

List of Figures

• Figure 1. Global Drug Discovery Outsourcing Market Snapshot: Market Value (US$ Mn), 2020-2034
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Drug Discovery Outsourcing Market
• Figure 5. Global Drug Discovery Outsourcing Market Analysis, By Drug Type, 2020, 2024 and 2034
• Figure 6. Global Drug Discovery Outsourcing Market Attractiveness Analysis, By Drug Type
• Figure 7. Global Drug Discovery Outsourcing Market Analysis, By Service Type, 2020, 2024 and 2034
• Figure 8. Global Drug Discovery Outsourcing Market Attractiveness Analysis, By Service Type
• Figure 9. Global Drug Discovery Outsourcing Market Analysis, By Therapeutic Area, 2020, 2024 and 2034
• Figure 10. Global Drug Discovery Outsourcing Market Attractiveness Analysis, By Therapeutic Area
• Figure 11. Global Drug Discovery Outsourcing Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 12. Global Drug Discovery Outsourcing Market Attractiveness Analysis, By End-User
• Figure 13. Global Drug Discovery Outsourcing Market Analysis, By Region, 2020, 2024 and 2034
• Figure 14. Global Drug Discovery Outsourcing Market Attractiveness Analysis, By Region
• Figure 15. North America Drug Discovery Outsourcing Market Analysis, By Drug Type, 2020, 2024 and 2034
• Figure 16. North America Drug Discovery Outsourcing Market Attractiveness Analysis, By Drug Type
• Figure 17. North America Drug Discovery Outsourcing Market (US$ Mn), by Small molecule, 2020-2034
• Figure 18. North America Drug Discovery Outsourcing Market (US$ Mn), by Large molecule, 2020-2034
• Figure 19. North America Drug Discovery Outsourcing Market Analysis, By Service Type, 2020, 2024 and 2034
• Figure 20. North America Drug Discovery Outsourcing Market Attractiveness Analysis, By Service Type
• Figure 21. North America Drug Discovery Outsourcing Market (US$ Mn), by Target Identification & Screening, 2020-2034
• Figure 22. North America Drug Discovery Outsourcing Market (US$ Mn), by Target Discovery & Validation, 2020-2034
• Figure 23. North America Drug Discovery Outsourcing Market (US$ Mn), by Hit Identification/High-Throughput Screening, 2020-2034
• Figure 24. North America Drug Discovery Outsourcing Market (US$ Mn), by Hit-to-Lead Development, 2020-2034
• Figure 25. North America Drug Discovery Outsourcing Market (US$ Mn), by Lead Optimization, 2020-2034
• Figure 26. North America Drug Discovery Outsourcing Market (US$ Mn), by Preclinical Testing Services, 2020-2034
• Figure 27. North America Drug Discovery Outsourcing Market (US$ Mn), by Others, 2020-2034
• Figure 28. North America Drug Discovery Outsourcing Market Analysis, By Therapeutic Area, 2020, 2024 and 2034
• Figure 29. North America Drug Discovery Outsourcing Market Attractiveness Analysis, By Therapeutic Area
• Figure 30. North America Drug Discovery Outsourcing Market (US$ Mn), by Oncology, 2020-2034
• Figure 31. North America Drug Discovery Outsourcing Market (US$ Mn), by Neurology/CNS Disorders, 2020-2034
• Figure 32. North America Drug Discovery Outsourcing Market (US$ Mn), by Infectious Diseases, 2020-2034
• Figure 33. North America Drug Discovery Outsourcing Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
• Figure 34. North America Drug Discovery Outsourcing Market (US$ Mn), by Immunology & Inflammatory Disorders, 2020-2034
• Figure 35. North America Drug Discovery Outsourcing Market (US$ Mn), by Metabolic & Endocrine Disorders, 2020-2034
• Figure 36. North America Drug Discovery Outsourcing Market (US$ Mn), by Respiratory Diseases, 2020-2034
• Figure 37. North America Drug Discovery Outsourcing Market (US$ Mn), by Gastrointestinal Disorders, 2020-2034
• Figure 38. North America Drug Discovery Outsourcing Market (US$ Mn), by Rare/Orphan Diseases, 2020-2034
• Figure 39. North America Drug Discovery Outsourcing Market (US$ Mn), by Ophthalmology Diseases, 2020-2034
• Figure 40. North America Drug Discovery Outsourcing Market (US$ Mn), by Dermatology Diseases, 2020-2034
• Figure 41. North America Drug Discovery Outsourcing Market (US$ Mn), by Others, 2020-2034
• Figure 42. North America Drug Discovery Outsourcing Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 43. North America Drug Discovery Outsourcing Market Attractiveness Analysis, By End-User
• Figure 44. North America Drug Discovery Outsourcing Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 45. North America Drug Discovery Outsourcing Market (US$ Mn), by Academic & Research Institutes, 2020-2034
• Figure 46. North America Drug Discovery Outsourcing Market Analysis, By Country, 2020, 2024 and 2034
• Figure 47. North America Drug Discovery Outsourcing Market Attractiveness Analysis, By Country
• Figure 48. Europe Drug Discovery Outsourcing Market Analysis, By Drug Type, 2020, 2024 and 2034
• Figure 49. Europe Drug Discovery Outsourcing Market Attractiveness Analysis, By Drug Type
• Figure 50. Europe Drug Discovery Outsourcing Market (US$ Mn), by Small molecule, 2020-2034
• Figure 51. Europe Drug Discovery Outsourcing Market (US$ Mn), by Large molecule, 2020-2034
• Figure 52. Europe Drug Discovery Outsourcing Market Analysis, By Service Type, 2020, 2024 and 2034
• Figure 53. Europe Drug Discovery Outsourcing Market Attractiveness Analysis, By Service Type
• Figure 54. Europe Drug Discovery Outsourcing Market (US$ Mn), by Target Identification & Screening, 2020-2034
• Figure 55. Europe Drug Discovery Outsourcing Market (US$ Mn), by Target Discovery & Validation, 2020-2034
• Figure 56. Europe Drug Discovery Outsourcing Market (US$ Mn), by Hit Identification/High-Throughput Screening, 2020-2034
• Figure 57. Europe Drug Discovery Outsourcing Market (US$ Mn), by Hit-to-Lead Development, 2020-2034
• Figure 58. Europe Drug Discovery Outsourcing Market (US$ Mn), by Lead Optimization, 2020-2034
• Figure 59. Europe Drug Discovery Outsourcing Market (US$ Mn), by Preclinical Testing Services, 2020-2034
• Figure 60. Europe Drug Discovery Outsourcing Market (US$ Mn), by Others, 2020-2034
• Figure 61. Europe Drug Discovery Outsourcing Market Analysis, By Therapeutic Area, 2020, 2024 and 2034
• Figure 62. Europe Drug Discovery Outsourcing Market Attractiveness Analysis, By Therapeutic Area
• Figure 63. Europe Drug Discovery Outsourcing Market (US$ Mn), by Oncology, 2020-2034
• Figure 64. Europe Drug Discovery Outsourcing Market (US$ Mn), by Neurology/CNS Disorders, 2020-2034
• Figure 65. Europe Drug Discovery Outsourcing Market (US$ Mn), by Infectious Diseases, 2020-2034
• Figure 66. Europe Drug Discovery Outsourcing Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
• Figure 67. Europe Drug Discovery Outsourcing Market (US$ Mn), by Immunology & Inflammatory Disorders, 2020-2034
• Figure 68. Europe Drug Discovery Outsourcing Market (US$ Mn), by Metabolic & Endocrine Disorders, 2020-2034
• Figure 69. Europe Drug Discovery Outsourcing Market (US$ Mn), by Respiratory Diseases, 2020-2034
• Figure 70. Europe Drug Discovery Outsourcing Market (US$ Mn), by Gastrointestinal Disorders, 2020-2034
• Figure 71. Europe Drug Discovery Outsourcing Market (US$ Mn), by Rare/Orphan Diseases, 2020-2034
• Figure 72. Europe Drug Discovery Outsourcing Market (US$ Mn), by Ophthalmology Diseases, 2020-2034
• Figure 73. Europe Drug Discovery Outsourcing Market (US$ Mn), by Dermatology Diseases, 2020-2034
• Figure 74. Europe Drug Discovery Outsourcing Market (US$ Mn), by Others, 2020-2034
• Figure 75. Europe Drug Discovery Outsourcing Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 76. Europe Drug Discovery Outsourcing Market Attractiveness Analysis, By End-User
• Figure 77. Europe Drug Discovery Outsourcing Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 78. Europe Drug Discovery Outsourcing Market (US$ Mn), by Academic & Research Institutes, 2020-2034
• Figure 79. Europe Drug Discovery Outsourcing Market Analysis, By Country, 2020, 2024 and 2034
• Figure 80. Europe Drug Discovery Outsourcing Market Attractiveness Analysis, By Country
• Figure 81. Asia Pacific Drug Discovery Outsourcing Market Analysis, By Drug Type, 2020, 2024 and 2034
• Figure 82. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, By Drug Type
• Figure 83. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Small molecule, 2020-2034
• Figure 84. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Large molecule, 2020-2034
• Figure 85. Asia Pacific Drug Discovery Outsourcing Market Analysis, By Service Type, 2020, 2024 and 2034
• Figure 86. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, By Service Type
• Figure 87. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Target Identification & Screening, 2020-2034
• Figure 88. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Target Discovery & Validation, 2020-2034
• Figure 89. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Hit Identification/High-Throughput Screening, 2020-2034
• Figure 90. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Hit-to-Lead Development, 2020-2034
• Figure 91. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Lead Optimization, 2020-2034
• Figure 92. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Preclinical Testing Services, 2020-2034
• Figure 93. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Others, 2020-2034
• Figure 94. Asia Pacific Drug Discovery Outsourcing Market Analysis, By Therapeutic Area, 2020, 2024 and 2034
• Figure 95. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, By Therapeutic Area
• Figure 96. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Oncology, 2020-2034
• Figure 97. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Neurology/CNS Disorders, 2020-2034
• Figure 98. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Infectious Diseases, 2020-2034
• Figure 99. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
• Figure 100. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Immunology & Inflammatory Disorders, 2020-2034
• Figure 101. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Metabolic & Endocrine Disorders, 2020-2034
• Figure 102. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Respiratory Diseases, 2020-2034
• Figure 103. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Gastrointestinal Disorders, 2020-2034
• Figure 104. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Rare/Orphan Diseases, 2020-2034
• Figure 105. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Ophthalmology Diseases, 2020-2034
• Figure 106. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Dermatology Diseases, 2020-2034
• Figure 107. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Others, 2020-2034
• Figure 108. Asia Pacific Drug Discovery Outsourcing Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 109. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, By End-User
• Figure 110. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 111. Asia Pacific Drug Discovery Outsourcing Market (US$ Mn), by Academic & Research Institutes, 2020-2034
• Figure 112. Asia Pacific Drug Discovery Outsourcing Market Analysis, By Country, 2020, 2024 and 2034
• Figure 113. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, By Country
• Figure 114. Latin America Drug Discovery Outsourcing Market Analysis, By Drug Type, 2020, 2024 and 2034
• Figure 115. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, By Drug Type
• Figure 116. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Small molecule, 2020-2034
• Figure 117. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Large molecule, 2020-2034
• Figure 118. Latin America Drug Discovery Outsourcing Market Analysis, By Service Type, 2020, 2024 and 2034
• Figure 119. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, By Service Type
• Figure 120. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Target Identification & Screening, 2020-2034
• Figure 121. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Target Discovery & Validation, 2020-2034
• Figure 122. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Hit Identification/High-Throughput Screening, 2020-2034
• Figure 123. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Hit-to-Lead Development, 2020-2034
• Figure 124. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Lead Optimization, 2020-2034
• Figure 125. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Preclinical Testing Services, 2020-2034
• Figure 126. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Others, 2020-2034
• Figure 127. Latin America Drug Discovery Outsourcing Market Analysis, By Therapeutic Area, 2020, 2024 and 2034
• Figure 128. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, By Therapeutic Area
• Figure 129. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Oncology, 2020-2034
• Figure 130. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Neurology/CNS Disorders, 2020-2034
• Figure 131. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Infectious Diseases, 2020-2034
• Figure 132. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
• Figure 133. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Immunology & Inflammatory Disorders, 2020-2034
• Figure 134. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Metabolic & Endocrine Disorders, 2020-2034
• Figure 135. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Respiratory Diseases, 2020-2034
• Figure 136. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Gastrointestinal Disorders, 2020-2034
• Figure 137. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Rare/Orphan Diseases, 2020-2034
• Figure 138. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Ophthalmology Diseases, 2020-2034
• Figure 139. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Dermatology Diseases, 2020-2034
• Figure 140. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Others, 2020-2034
• Figure 141. Latin America Drug Discovery Outsourcing Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 142. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, By End-User
• Figure 143. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 144. Latin America Drug Discovery Outsourcing Market (US$ Mn), by Academic & Research Institutes, 2020-2034
• Figure 145. Latin America Drug Discovery Outsourcing Market Analysis, By Country, 2020, 2024 and 2034
• Figure 146. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, By Country
• Figure 147. Middle East & Africa Drug Discovery Outsourcing Market Analysis, By Drug Type, 2020, 2024 and 2034
• Figure 148. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, By Drug Type
• Figure 149. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Small molecule, 2020-2034
• Figure 150. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Large molecule, 2020-2034
• Figure 151. Middle East & Africa Drug Discovery Outsourcing Market Analysis, By Service Type, 2020, 2024 and 2034
• Figure 152. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, By Service Type
• Figure 153. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Target Identification & Screening, 2020-2034
• Figure 154. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Target Discovery & Validation, 2020-2034
• Figure 155. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Hit Identification/High-Throughput Screening, 2020-2034
• Figure 156. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Hit-to-Lead Development, 2020-2034
• Figure 157. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Lead Optimization, 2020-2034
• Figure 158. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Preclinical Testing Services, 2020-2034
• Figure 159. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Others, 2020-2034
• Figure 160. Middle East & Africa Drug Discovery Outsourcing Market Analysis, By Therapeutic Area, 2020, 2024 and 2034
• Figure 161. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, By Therapeutic Area
• Figure 162. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Oncology, 2020-2034
• Figure 163. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Neurology/CNS Disorders, 2020-2034
• Figure 164. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Infectious Diseases, 2020-2034
• Figure 165. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
• Figure 166. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Immunology & Inflammatory Disorders, 2020-2034
• Figure 167. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Metabolic & Endocrine Disorders, 2020-2034
• Figure 168. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Respiratory Diseases, 2020-2034
• Figure 169. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Gastrointestinal Disorders, 2020-2034
• Figure 170. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Rare/Orphan Diseases, 2020-2034
• Figure 171. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Ophthalmology Diseases, 2020-2034
• Figure 172. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Dermatology Diseases, 2020-2034
• Figure 173. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Others, 2020-2034
• Figure 174. Middle East & Africa Drug Discovery Outsourcing Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 175. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, By End-User
• Figure 176. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 177. Middle East & Africa Drug Discovery Outsourcing Market (US$ Mn), by Academic & Research Institutes, 2020-2034
• Figure 178. Middle East & Africa Drug Discovery Outsourcing Market Analysis, By Country, 2020, 2024 and 2034
• Figure 179. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, By Country